Department of Otolaryngology, Kuang-Tien General Hospital, Taichung, Taiwan.
Am J Rhinol Allergy. 2013 Jul-Aug;27(4):e96-100. doi: 10.2500/ajra.2013.27.3939.
Patients who suffer from hyposmia and anosmia report a negative effect on their overall quality of life. Smell disturbance of patients with chronic rhinosinusitis (CRS) can improve after endoscopic sinus surgery (ESS). Although several studies have shown that 50-83% of patients may notice an improvement in olfactory function after ESS, the olfactory improvement after revision ESS (RESS), especially by objective measurements, is still lacking.
Olfactory function was assessed by the traditional Chinese version of the University of Pennsylvania Smell Identification Test (UPSIT-TC) preoperatively and postoperatively, recorded as smell identification test (SIT) score. Olfactory outcomes from anosmia to hyposmia/normosmia, or from hyposmia to normosmia, were considered as "improvement." Postoperative assessments were divided into two periods: period 1 (P1) is defined as >6 but <12 months postoperatively; period 2 (P2) is defined as >12 but <24 months postoperatively.
Thirty-two patients with smell disturbance preoperatively (period 0 [P0]) and confirmed by UPSIT-TC were enrolled into this study. Mean SIT score at P0 was 13.3; mean SIT score at P1 was 18.6; mean SIT score at P2 was 20.4. The presence of nasal polyps blocking the olfactory cleft were associated with better olfaction improvements (p < 0.05) as was the degree of mucosal swelling. The overall improvement rates were 44.8 and 47.8% at P1 and P2, respectively.
RESS resulted in objective evidence of olfactory improvement in approximately one-half of our cohort over 16 months of follow-up and offers a treatment option for an otherwise poor prognosis condition.
患有嗅觉减退和嗅觉丧失的患者报告称,这对他们的整体生活质量有负面影响。慢性鼻-鼻窦炎(CRS)患者的嗅觉障碍在接受内镜鼻窦手术(ESS)后可以得到改善。尽管多项研究表明,50-83%的患者在 ESS 后可能会注意到嗅觉功能有所改善,但 ESS 后修正手术(RESS)后的嗅觉改善,特别是通过客观测量,仍然缺乏。
嗅觉功能通过传统的中文版宾夕法尼亚嗅觉识别测试(UPSIT-TC)在术前和术后进行评估,记录为嗅觉识别测试(SIT)评分。从嗅觉丧失到嗅觉减退/正常,或从嗅觉减退到正常,被认为是“改善”。术后评估分为两个时期:第 1 期(P1)定义为术后>6 但<12 个月;第 2 期(P2)定义为术后>12 但<24 个月。
本研究共纳入 32 例术前(第 0 期[P0])有嗅觉障碍且经 UPSIT-TC 证实的患者。P0 时平均 SIT 评分为 13.3;P1 时平均 SIT 评分为 18.6;P2 时平均 SIT 评分为 20.4。嗅裂被鼻息肉阻塞导致嗅觉改善较好(p<0.05),黏膜肿胀程度也是如此。在 P1 和 P2 时,总体改善率分别为 44.8%和 47.8%。
在 16 个月的随访中,RESS 为大约一半的患者提供了嗅觉改善的客观证据,并为预后不良的情况提供了一种治疗选择。